Pharmacologic treatments for covid-19 patients

Ensitrelvir vs Placebo


Outpatients

Forest plots
(last update: 2022-11-22)

Summary of findings
(last update: 2022-11-24)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=808

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
jRCT2031210350
Mukae H, medRxiv, 2022 b
Full text
Commentary
Commentary
Mixed

Ensitrelvir 125

Ensitrelvir 250

Placebo

RCT Patients with confirmed COVID-19 (mild ambulatory) treated or isolated at 87 centers in Japan and South Korea. N=428
Some concerns
Details

Full description

jRCT2031210350
Mukae H, Antimicrob Agents Chemother, 2022 a
Full text
Full text
Commentary
Commentary
Commentary
Mixed

Ensitrelvir 125

Ensitrelvir 250

Placebo

RCT Outpatients and inpatients with confirmed COVID-19 (asymptomatic to mild) treated or isolated at 56 centers in Japan. N=69
Some concerns
Details

Full description